Investigating the mechanism of oridonin against triple-negative breast cancer based on network pharmacology and molecular docking. Zhao Y, Lan S, Li X, Deng Y, et al. PLoS One 2025;20:e0332697.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao Y, Lan S, Li X, Deng Y, et al. Investigating the mechanism of oridonin against triple-negative breast cancer based on network pharmacology and molecular docking. PLoS One 2025;20:e0332697.
PMID: 41325388